Exclusive: CureVac becomes second company to test coronavirus vaccine in Germany – sources

  • Current Events
  • Exclusive: CureVac becomes second company to test coronavirus vaccine in Germany – sources

FRANKFURT (Reuters) – The unlisted biotech firm CureVac will become the second company to launch human trials of an experimental coronavirus vaccine in Germany, two people familiar with the plans told Reuters on Tuesday.

The clinical trial, to be announced on Wednesday, is the second to be approved by Germany’s vaccines regulator, the Paul Ehrlich Institute, after a trial by BioNTech that began in April.

CureVac and the Paul Ehrlich Institute declined to comment.

The World Health Organization lists 11 experimental coronavirus vaccines as currently being tested on humans, according to a table posted on its website.

The German government on Monday unveiled a deal to take an agreed 23% stake in CureVac for a cash injection of 300 million euros ($338 million).

Later that day, a finance ministry document seen by Reuters showed that the firm – controlled by SAP co-founder Dietmar Hopp – plans an initial public offering in the United States next month.

Germany and partner countries in the European Union last week pledged funds for the production of an experimental vaccine being developed by the University of Oxford and AstraZeneca, saying they needed to spread their bets across several more candidates.

Britain and the United States had previously made commitments to secure hundreds of millions of doses of the AstraZeneca vaccine, which is based on so-called viral vector technology, as developers across the world prepare to produce even before their candidates are shown to work in trials.

Media reports in March that the United States had tried to gain access to CureVac or its vaccine stirred a political backlash in Germany, where members of the government called for it to remain German-owned.

CureVac’s management has denied receiving offers from the United States.

The company, which is based in Tuebingen and backed by the Bill & Melinda Gates Foundation, is using the so-called messenger RNA approach, like BioNTech and its partner Pfizer as well as Moderna.

Translate Bio and its partner Sanofi are also working on a messenger RNA vaccine against the coronavirus.

Reporting by Ludwig Burger and Patricia Weiss; Editing by Kevin Liffey

Our Standards:The Thomson Reuters Trust Principles.

Did you like this article? You can read it and many others @ Reuters!

FRESHEST

Here's the latest news

The star anchor Chris Cuomo was fired by CNN on Saturday amid a network inquiry into his efforts to help his brother, Andrew M. Cuomo, then the governor of New York, fight off a sexual harassment scandal.“Chris Cuomo was suspended...

CNN Fires Chris Cuomo Over His Efforts to Help Andrew

After a disappointing midweek 0-0 result at home, Paris Saint-Germain will not want to fuel the title hopes of any of its challengers by dropping more points when it faces Lens on the road. PSG has a comfortable 12-point lead in...

PSG vs. Lens live score, updates, highlights from Ligue 1, Matchday 17

Photography courtesy of Kanya Iwana Including the launch of gender-inclusive intimates. By Sarah Mariotti Date December 4, 2021 Moose Knuckles collaborates with LA-based jewellery designer Photography courtesy of Kanya IwanaThrough a shared reverence for sisterhood, Canadian luxury outerwear brand Moose...

Moose Knuckles Gets the Fine Jewellery Treatment + More Fashion News

We love these products, and we hope you do too. E! has affiliate relationships, so we may get a small share of the revenue from your purchases. Items are sold by the retailer, not E!. Prices are accurate as of...

National Cookie Day Deals: Mrs. Fields, Cheryl's, Milk Bar & More

As LeBron James took the podium for his postgame press conference, after the Lakers lost to the Clippers 119-115, the result of the game was almost inconsequential.  Given that this was his first media availability, since clearing the NBA's health...

LeBron James discusses clearing NBA's COVID-19 protocols early, details frustration over confusing past few days
Load More
Share via
Copy link
Powered by Social Snap